Journal of Evolving Stem Cell Research

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Evolving Stem Cell Research-My laboratory investigates the key cellular components such as effector T cells-Yi Zhang

China

Biotherapy Center & Department of Oncology,
The First Affiliated Hospital of Zhengzhou University.

Send an Email

Yi Zhang

Address:

Jianshedonglu, Zhengzhou 450052, China,
Henan, China.

Research Interests:

  • My laboratory investigates the key cellular components such as effector T cells, regulatory immune cells and caner stem cells in tumor microenvironment and their clinical relevance, especially in lung cancer and esophageal cancer.
  • We concentrate on the aberrant expression of cancer-testis (CT) antigens and the corresponding antigen-specific T cells in lung cancer and esophageal cancer.
  • Furthermore, we are dedicated to develop TCR or CAR gene-modified T cells and against tumor antigens for potential antigen-specific T cell therapy.

Biography:

  • Dr. Yi Zhang obtained his PhD degree at University Catholique de Louvain in Belgium and did his postdoctoral training in Drs Thierry Boon and Pierre van der Bruggen’s lab in Ludwig Institute for Cancer Research, Brussels Branch. 
  • After that, he moved to University of Chicago and worked as Research Assistant Professor in Dr. Hans Schreiber’s lab. 
  • In 2005, he was recruited as Tenure-track Assistant Professor in Medical University of South Carolina. 
  • Currently, he is a distinguished Professor and Director in Biotherapy Center & Department of Oncology at the First Affiliated Hospital of Zhengzhou University. 
  • His laboratory investigates the key cellular components such as effector T cells, regulatory immune cells and caner stem cells in tumor microenvironment and their clinical relevance,especially in lung cancer and esophageal cancer. 
  • He concentrates on the aberrant expression of cancer-testis (CT) antigens (such as MAGE-A3, MAGE-C2, NY-ESO-1 etc.) and the corresponding antigen-specific T cells in lung cancer and esophageal cancer. 
  • Furthermore, they are dedicated to develop TCR or CAR gene-modified T cells and against tumor antigens for potential antigen-specific T cell therapy. 
  • He published 135 papers and more than 60 publications in internationally peer-reviewed journals.
  • He published 135 papers and more than 60 publications in internationally peer-reviewed journals.
  • He published 135 papers and more than 60 publications in internationally peer-reviewed journals.